Onur Cetin
Homburg, SL, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.
Journal: British journal of haematology
Published: February 18, 2026
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.
Journal: Nature communications
Published: March 13, 2025
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients.
Journal: Molecular cancer
Published: June 20, 2024
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis.
Journal: Immunology letters
Published: June 04, 2024
Autoantibodies against SUMO1-DHX35 in long-COVID.
Journal: Journal of translational autoimmunity
Published: November 13, 2022
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.
Journal: EJHaem
Published: September 30, 2022
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
Journal: The New England journal of medicine
Published: September 21, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2.
Journal: Expert review of vaccines
Published: August 22, 2022
Last Updated: 09/26/2026